These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9551410)

  • 1. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
    Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L; Parving HH; Jacobsen P; Rossing P; Lecerf L; Poirier O; Cambien F
    Ugeskr Laeger; 1998 Aug; 160(34):4886-9. PubMed ID: 9741257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Boelskifte S; Borch-Johnsen K
    Diabetologia; 1995 Jul; 38(7):798-803. PubMed ID: 7556981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Kidney Int; 2002 Jul; 62(1):192-8. PubMed ID: 12081578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Parving HH
    Diabetes; 1995 May; 44(5):489-94. PubMed ID: 7729604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Diabetes Care; 2003 May; 26(5):1501-6. PubMed ID: 12716812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.
    Pfohl M; Frost D; Koch M; Clemens P; Patzies A; Schmülling RM; Beischer W; Häring HU
    Horm Metab Res; 1998 May; 30(5):276-80. PubMed ID: 9660089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
    Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
    Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics.
    Azar ST; Zalloua PA; Medlej R; Halabi G
    Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DD genotype of angiotensin-converting enzyme in type 2 diabetes mellitus with renal disease in Mexican Mestizos.
    Palomo-Piñón S; Gutiérrez-Rodríguez ME; Díaz-Flores M; Sánchez-Barrera R; Valladares-Salgado A; Utrera-Barillas D; Durán-Reyes G; Galván-Duarte RE; Trinidad-Ramos P; Cruz M
    Nephrology (Carlton); 2009 Apr; 14(2):235-9. PubMed ID: 19207872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.